bit.bio cell therapy pipeline featured in Endpoints News
Endpoints News did an exclusive interview with bit.bio's CEO after the cell therapy pipeline announcement with an initial focus on the liver.
Endpoints News did an exclusive interview with bit.bio's CEO after the cell therapy pipeline announcement with an initial focus on the liver.